Cash, cash equivalents, and marketable securities totaled $420.8 million as of December 31, 2024. Septerna (SEPN) expects its current cash position to support its planned operations into early 2028.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SEPN:
- Septerna, Inc. Shifts Focus to Next-Gen PTH1R Agonist
- Hold Rating for Septerna, Inc. Amid Lead Program Discontinuation and Pipeline Uncertainty
- Wells Fargo downgrades Septerna after lead program SEP-786 discontinued
- Septerna downgraded to Equal Weight from Overweight at Wells Fargo
- Septerna discontinues SEP-786 Phase 1 clinical trial in hypoparathyroidism